Dear BPM Community,
The community has had a very active 2025 and the leadership team wanted to end the year highlighting some of the community's accomplishments.
We've pulled them together here: AAPS BPM Community 2025 Year in Review
The release of the 2025 FDA BMVB guidance was a prominent focus this year, prompting a series of activities that encouraged reflection, discussion, and consensus. From an OSD to an AAPSJ editorial to a Hot Topic session at 2025 PharmSci360, our community has driven conversations that are highly impactful. Thank you for being a part of them!
What activities from this year did you find most meaningful?
What types of activities would you like to see more of in the new year?
Please let us know!
Thank you and happy holidays!
Best,
The BPM Community Leadership Team
------------------------------
Karen Quadrini, PhD
Director, Clinical Biomarkers
Prothena Biosciences
Brisbane, CA
[email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------